Lanreotide
Lanreotide is a premium-grade, synthetic octapeptide active pharmaceutical ingredient (API) with CAS number 108736-35-2. This high-purity somatostatin analogue is widely utilized across the global healthcare sector to manufacture clinical-strength prolonged-release injections, acromegaly therapies, and neuroendocrine tumor treatments.
Description
Comprehensive Product Overview of Lanreotide
Exceptional digestibility and rapid receptor affinity provide a major competitive advantage in the formulation of therapeutic treatments. This active pharmaceutical ingredient works by providing the essential structural mechanisms—specifically binding to somatostatin receptors to suppress endocrine secretion—needed for effective systemic modulation. It helps manufacturers achieve potent therapeutic profiles in oncology and endocrine products without sacrificing formula stability. For instance, Lanreotide is frequently used as a primary ingredient in clinical-strength acromegaly management setups. Consequently, it improves the final clinical efficacy of targeted neuroendocrine tumor suppression routines. As a result, Zyntex ensures low heavy metal content and strict microbiological control for our supply, ensuring maximum safety during your manufacturing cycle.
Moreover, Zyntex supplies specialized ultra-pure powder grades for the medical research and fine peptide compounding industries. This compound acts as a critical structural asset, helping to enhance the systemic regulatory mechanisms of biological matrices undergoing intense hormonal imbalances. It pushes the boundaries of medical science by offering a highly stable active source that does not affect the final blend’s processing parameters during gel formation. At the same time, it serves as a crucial biomaterial matrix in the synthesis of specialized prolonged-release matrices and targeted prescription intermediates. In short, our product serves as a dependable “structural matrix.” It supports both the vitality of the human body and the precision of modern biomedical engineering.
Key Industrial Applications for Lanreotide
This high-purity bioavailable peptide active substance is essential in these four primary sectors:
💉 Depo Injections
Primary active source for manufacturing autogel formulations and sustained-release deep subcutaneous formulations. Thus, it provides essential support for localized systemic delivery.
🏥 Tumor Regulation
Key drug block utilized for preventative gastroenteropancreatic neuroendocrine tumor care lines. Undoubtedly, it is vital for enhancing patient oncological benchmarks.
🔬 Peptide Assays
Used for targeted somatostatin receptor interaction testing and endocrine cell replication models. Consequently, it is vital for high-performance research control.
🧪 Fine Drug Synthesis
Acts as an essential reference standard block for modern amino acid sequencing and biochemical compounding trials. Specifically, it supports rapid compounding and formula clarity.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Lanreotide Acetate |
| Assay / Purity (HPLC) | ≥ 98.0% |
| Appearance | White to off-white amorphous powder |
| Acetate Content | 5.0% – 12.0% |
| Bacterial Endotoxins | Strictly compliant with pharmaceutical injection limits |
| CAS Number | 108736-35-2 (Free Base: 108736-33-0) |
📝 Safety & Handling: Formulated strictly for controlled pharmaceutical manufacturing, hormone compounding, and clinical laboratory oncology workflows. Lanreotide is a highly potent endocrine modulator that alters systemic growth hormone and endocrine pathways, and may cause skin irritation or gastrointestinal sensitivity upon accidental occupational exposure. Peptides are highly heat-sensitive and prone to hydrolysis. Therefore, store strictly in a deep-freeze environment between -20°C and -15°C, completely protected from light, ambient moisture, and oxygen fields in its original tight safety-sealed packaging. Avoid airborne powder generation or prolonged exposure to room temperature during manufacturing scales. Operating within a certified sterile environment, utilizing vertical laminar flow hoods, and wearing full laboratory protective equipment (PPE)—including sterile double gloves, protective gowns, and certified particulate respirators—is strictly mandatory. Always consult the Safety Data Sheet (SDS) for comprehensive handling regulations.
